SouthCrest Financial Group Reports preliminary 2Q17

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
117
SouthCrest Financial Group Reports preliminary 2Q17 earnings: Net income over $1M

ATLANTA, July 20, 2017 (GLOBE NEWSWIRE) -- Brian D. Schmitt, Chief Executive Officer of SouthCrest Financial Group, Inc. (SCSG:PK) announced today that the Company reported preliminary net income of $1.02M or $0.12/share for the second quarter ended June 30, 2017.

“As planned, both SouthCrest Bank and SouthCrest Financial Group are now operating out of our new headquarters in midtown Atlanta, and we intend for our loan and deposit growth in the core Atlanta market to grow substantially,” said Schmitt. “Now with our four locations in and around Atlanta, we will focus strategically on having 50% of our total assets and 25% of our deposits in what we consider the core 13 counties at the center of the MSA.

“As of the end of June, we had 37% of our loans and 12% of our deposits in these counties. We are on track for planned future growth,” Schmitt explained. “These will be the metrics we will use to track the success of our Atlanta growth initiative.

“Tangible book value grew to $7.41/share, up over $0.20 from the end of March. Total loans grew 6.5% year over year and 9.5% on a linked quarter annualized (LQA) basis to $300 million.  During the quarter, we closed on the sale of a small credit card portfolio that benefitted the quarter by approximately $160,000 after tax, or $0.02/share, making core earnings $0.10/share.

“As is the norm for SouthCrest due to seasonality, deposits declined slightly in the second quarter from the first quarter, and are down 2.8% from 2Q16. This is primarily due to the strategic decisions made regarding locations and fees that occurred in 2016. This has generally been the magnitude of the decline on a year over year basis for the past few quarters, between 2-3%,” Schmitt explained.

“We have regulatory approval to close the sale of our two Alabama branches, which is now scheduled for September.  The process has required more time to complete than anticipated, but ultimately we believe this strategic move is a net positive for SouthCrest’s shareholders, and will be beneficial for our Alabama based customers.”   

On a core basis, expenses for the quarter were $4.4 million, flat with the past few quarters, but down over 5% from 2Q16.

Loan activity remained improved from the end of the first quarter through this writing, and management expects continued growth in 2H17. In addition, the Company continues to recruit in the core Metro area for top quality lenders to increase the percentage of total assets to hit the 50% target.  

The estimated Tier 1 Leverage ratio at the end of the quarter for SouthCrest Bank increased to 9.31%.  On a fully converted basis (including the conversion of all preferred equity), TBV/share ended the quarter at $7.41 per share.  This metric will continue to be influenced by OCI changes resulting from the swings in interest rates. Currently, the negative impact to TBV by OCI is just $0.02/share. The current fully converted share count at the end of the quarter is 8.40 million shares. In addition, the Company still retains a small deferred tax asset valuation allowance related to state taxes that totals approximately $0.06/fully converted share.

Asset quality improved further during the quarter, with NPAs to assets declining to 0.76% from 0.84%, excluding the $2.1 million of former bank buildings that are projected to be sold over the next several quarters in OREO.  Including these buildings, 2Q17 NPAs/total assets were 1.16% of assets vs. 1.23% in 1Q17. Excluding the impact of the Bank buildings in OREO, OREO balances were down to a cycle low of $86,000.   

ABOUT SOUTHCREST

SouthCrest Financial Group, Inc. is a $540 million asset bank holding company headquartered in Atlanta, GA.  The company operates a 10 branch network throughout Georgia and Alabama through its subsidiary bank, SouthCrest Bank, N.A.  The bank provides a full suite of retail, private, entrepreneurial, high-net-worth and commercial banking services, and online banking services. 

FORWARD LOOKING STATEMENTS

This presentation may contain certain “forward-looking statements” that are subject to risks, uncertainties, and other factors that could cause actual results and shareholder values to differ materially from those projected.  Factors that could cause or contribute to such differences include economic conditions, government regulation and legislation, changes in interest rates, credit quality, competition, and other risk factors. 

Andy Borrmann Chief Financial Officer 678.734.3505

Statement of Operations ($000s, Unaudited)
    2016           2017  
 Q2  Q3  Q4  Q1  Q2  
Interest Income                
Loans                
Construction and Development$143 $153 $150 $197 $198  
Commercial Real Estate 1,479  1,537  1,645  1,691  1,737  
Commercial Loans 280  276  291  316  341  
Multi Family 18  18  31  27  26  
Residential Mortgage 1,337  1,289  1,230  1,190  1,209  
Consumer Loans 156  139  122  117  109  
County/Municipal Loans 28  29  42  25  25  
Loss Share Loans 132  132  119  111  33  
Investment Securities    
Federal Funds/Overnight Funds$27 $42 $28 $58 $77  
Bank Owned CDs 8  6  6  5  6  
Investment Securities 1,083  933  1,039  967  872  
Total Interest Income $ 4,685 $ 4,556 $ 4,703 $ 4,705 $ 4,633  
    
Total Interest Expense $267 $246 $247 $249 $250  
Net Interest Income $4,417 $4,311 $4,456 $4,456 $4,383  
Provision for Loan Losses 0  0  94  106  70  
Net Interest Income after Loan Losses $4,417 $4,311 $4,362 $4,349 $4,314  
Other Income   
Service Charges on Deposits$215 $245 $228 $216 $209  
NSF/Overdraft Fees 515  575  542  488  491  
Other Service Charges 79  96  83  75  78  
ATM/Billpay/DR Card Income 336  302  303  296  307  
Other Income (47)  339  -386  451  541  
Total Other Income $1,098 $1,560 $768 $1,526 $1,626  
Non-Interest Expense    
Salaries, Other Comp (+ FAS123R)$1,772 $1,705 $2,014 $1,799 $1,874  
Employee Benefits 360  707  463  438  378  
Occupancy & FF&E Expense 848  860  764  739  765  
Professional Fees 209  212  190  190  157  
Data Processing 521  536  525  498  549  
OREO/Credit related Exp. 36  36  36  50  (27)  
Other Expense 927  861  694  766  734  
Total Noninterest Expenses$4,673 $4,917 $4,687 $4,480 $4,430  
Pre-Tax Income (Loss)$842 $954 $443 $1,395 $1,510  
Income Taxes (10,592)  274  128  465  488  
Net Income$11,434 $680 $315 $930 $1,022  
Preferred Dividends$125 $125 $125 $125 $57  
 
 
Balance Sheet ($000s, Unaudited) 
   2016          2017
Assets  Q2  Q3  Q4  Q1  Q2
Current Assets               
Cash & Due from Bank $34,838 $31,268 $33,015 $41,302 $31,852
Federal Funds/Overnight Funds  569  0  4,299  6,688  5,355
Bank Owned CDs  1,716  1,218  1,069  1,069  1,069
Investment Securities  161,177  182,614  176,723  152,583  144,740
Total Current Assets $ 198,300  $ 215,100  $ 215,106  $ 201,642  $183,016
Loans        
Construction and Development $11,285 $9,776 $15,159 $12,486 $15,604
Commercial Real Estate  119,419  121,609  138,155  140,003  143,883
Commercial Loans  21,863  21,247  23,462  23,923  27,884
Multi Family  1,419  1,401  2,281  2,093  2,050
Residential Mortgage  107,270  102,512  97,194  98,302  95,682
Consumer Loans  7,977  7,363  6,893  6,117  5,874
County/Municipal Loans  4,501  6,456  3,387  2,999  2,971
Loss Share Loans  7,689  7,589  7,123  6,626  5,755
Total Loans $281,425  $277,952  $293,654  $292,549  $299,703
Allowance for Loss  (2,817)  (2,701)  (2,766)  (2,797)  (2,875)
Net Loans $ 278,608  $ 275,251  $ 290,888  $ 289,752  $ 296,828
OREO  1,769  936  3,581  2,728  2,315
FDIC Indemnification  433  425  304  238  112
BOLI  20,548  20,683  20,816  20,947  21,094
Fixed Assets, net $17,362 $16,967 $13,717 $13,429 $13,406
Intangible Assets  555  507  468  420  373
Other Assets   33,982    16,476    17,953    17,428    16,564
Total Assets $551,557  $546,385  $562,833  $546,584  $533,708
Liabilities & Stockholders' Equity      
Liabilities     
Deposits     
DDAs $112,974 $111,290 $125,459 $112,286 $106,968
Interest Bearing Demand  55,248  54,552  65,654  63,949  63,481
Celebration Checking  110,894  111,544  112,355  113,548  112,731
Money Market Accts  33,858  33,956  32,271  27,942  28,689
Savings  53,397  52,061  50,495  51,304  51,095
CDs Less Than $100k  76,301  73,964  72,091  70,020  67,892
CDs Greater than $100k  40,585   39,832   38,922   39,966   38,952
Total Deposits  $ 483,257  $ 477,388  $ 497,247  $ 479,018  $ 469,809
                
Other Liabilities  1,919  2,281  1,252  1,632  1,763
Net Borrowings (Wholesale Funding)  -  317  -  -  -
Total Liabilities $ 485,176 $479,797 $498,499 $480,650 $471,572
Total Equity  66,381  66,548  64,334  65,934  62,136
Total Liabilities & Stockholders' Equity $551,557 $546,345 $562,833 $546,584 $533,708
                
Ratios  2Q 2016  3Q 2016*  4Q 2016*  1Q 2017*  2Q 2017*
ROAA  6.30%  0.54%  0.48%  0.72%  0.76%
ROAE  62.07%  4.77%  4.44%  6.78%  6.57%
NPAs/Assets (Core)  1.08%  0.91%  0.83%  0.84%  0.76%
Est. T1 Leverage (Bank)  9.00%  9.31%  9.26%  8.87%  9.31%
Total Common Equiv. Shares  8,380,337  8,380,337  8,389,954  8,389,954  8,395,696
NIM  3.59%  3.58%  3.63%  3.67%  3.68%
Cost of Funds  0.22%  0.20%  0.20%  0.20%  0.21%
Loan/Deposit  58.2%  58.2%  59.0%  60.3%  63.7%
Employees  127  123  122  122  122

*3Q2016 and later ROAA and ROAE are after tax vs. pre-tax prior to 2Q 2016.  2Q 2016 includes DTA valuation allowance recovery.

Contact: Andrew Bowen, APR ab@clearviewcom.com 404-822-3309

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Madrigal Faces Legal Scrutiny Amid Whistleblower Claims

Updated Category News Views 233

The Storm Brewing Over Madrigal Pharmaceuticals Well, folks, here we are smack dab in the middle of another roller-coaster ride in the biotech sector, and it ain't pretty. Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is in hot water with some serious allegations thrown their way. The company is now under investigation by Kessler Topaz Meltzer & Check, LLP, a top-notch...

Continue Reading
Key Players Depart No Makeup Makeup Amid Rapid Success

Updated Category News Views 214

Change is afoot in the world of beauty. No Makeup Makeup, a brand that's managed to carve out a sizable niche, recently bid farewell to two of its main architects: Kim Wileman and Shauna Lahiri. These women didn't just steer the ship; they built the damn thing. Kicking Off the No Makeup Revolution Wileman and Lahiri were the pistons firing away at No Makeup Makeup, a...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 212

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Koppers Faces Investigation: Investors Cautious Amid Probe

Updated Category News Views 211

Deep Dive: Koppers' Financial Turmoil When a company throws a financial party, you don't expect the hangover to come in the form of an investigation notice. That’s what’s brewing over at Koppers Holdings Inc., leading many seasoned investors to take a hard, scrutinizing look at the books. The latest buzz? An inquiry into whether the company gave its investors the full...

Continue Reading
DraftKings Faces Revenue Cutback; Legal Probe Begins

Updated Category News Views 190

DraftKings' Surprising Turn of Fortune Talk about a gut punch! DraftKings (NASDAQ: DKNG) dropped a bombshell that had investors reeling. They decided to lop off a hefty slice of their revenue guidance, and trust me, those aren't small numbers we’re talking about. On November 6, they yanked their full-year 2026 revenue guidance down to $6.35 billion to $6.55 billion from...

Continue Reading
Blue Owl Tech Faces Lawsuit Post-44% Share Dive

Updated Category News Views 59

The air's thick with tension for investors of Blue Owl Technology Finance Corp. (NYSE:OTF) as they wake up to the news of a securities class action lawsuit that's no small fry. You don’t have to look too far to see why the folks holding the bag might be steamed. We’re talking about a 44% drop in stock price since the merger with Blue Owl Technology Finance Corp....

Continue Reading
Tenax Therapeutics Faces Legal Heat After Stock Plunge

Updated Category News Views 133

Investors' Nerves Tested as Tenax Takes a Nosedive Holy smokes! When a biotech company like Tenax Therapeutics, Inc. (NASDAQ: TENX) detonates like a forgotten fireworks stash, investors have every right to get itchy. Tenax’s shocking announcement that their Phase 3 LEVEL trial for TNX-103 flopped has sparked more than just shareholder anxiety. It’s ignited a...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 151

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 82

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 206

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading

Top 5 Most Recently Viewed Articles

UGO Token Revolutionizes Trading with Innovative Launch

Updated Category News Views 216

UGO Token Launching on PancakeSwap UGO, the latest addition to the innovative ecosystem featuring Gooo and WeGo, is set to make waves in the trading sphere with its exceptional Hybrid Token Model. This new framework emphasizes fairness, sustainability, and real-world utility, offering an exciting opportunity for both everyday traders and crypto enthusiasts alike. What...

Continue Reading
Empyrean Anaheim Faces Legal Battle Over Wage Practices

Updated Category News Views 33

California Labor Law Clashes in the Spotlight When a lawsuit against a big name like Empyrean Anaheim Resort hits headlines, it raises eyebrows. Folks, we're talking about a class action filed in California, no less—a state with some of the toughest labor laws around. The legal eagles at Blumenthal Nordrehaug Bhowmik De Blouw LLP are on the case, claiming Empyrean...

Continue Reading
China's Diplomatic Efforts to Stabilize Middle East Oil Market

Updated Category News Views 174

China's Role in Mediating Middle Eastern Conflicts As the world’s second-largest oil consumer, China is stepping into a critical role by urging Israel and Iran to de-escalate their ongoing tensions. In this complex geopolitical landscape, China's top diplomat, Wang Yi, took proactive measures through separate phone calls with officials from both nations, advocating for...

Continue Reading
Jason Wyatt: Transforming Leadership and Achieving Success

Updated Category News Views 524

Jason Wyatt Recognized for His Exceptional Leadership In a remarkable acknowledgment by The Inner Circle, Jason Wyatt, an esteemed CEO, is honored as an Inner Circle Lifetime member. This recognition is a testament to his significant contributions to Transforming Leadership and Driving Success Through Innovative Coaching. Jason Wyatt's Innovative Approach to Leadership As...

Continue Reading
Terray Therapeutics Secures $120M Series B for Drug Innovation

Updated Category News Views 293

Terray Therapeutics Secures Significant Series B Investment Terray Therapeutics, a dynamic player in the biotechnology sector, has successfully closed an oversubscribed Series B funding round, raising $120 million. This investment aims to advance the company's unique generative AI pipeline for small molecule therapeutics, enhancing their capabilities to bring innovative...

Continue Reading